Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Joint Recommendations for the Public Health Informatics Infrastructure.

Miller C, Ishikawa C, DeLeon M, Huang M, Ising A, Bakota E.

J Public Health Manag Pract. 2015 Sep-Oct;21(5):516-8. doi: 10.1097/PHH.0000000000000325. No abstract available.

PMID:
26214538
2.

Effects of prenatal stress and neonatal handling on anxiety, spatial learning and serotonergic system of male offspring mice.

Akatsu S, Ishikawa C, Takemura K, Ohtani A, Shiga T.

Neurosci Res. 2015 Jul 9. pii: S0168-0102(15)00180-7. doi: 10.1016/j.neures.2015.07.002. [Epub ahead of print]

PMID:
26163770
3.

Constitutive expression of IRF-5 in HTLV-1-infected T cells.

Ishikawa C, Senba M, Barnes BJ, Mori N.

Int J Oncol. 2015 Jul;47(1):361-9. doi: 10.3892/ijo.2015.3020. Epub 2015 May 22.

PMID:
26004104
4.

Improvement of vocal pathologies diagnosis using high-speed videolaryngoscopy.

Tsuji DH, Hachiya A, Dajer ME, Ishikawa CC, Takahashi MT, Montagnoli AN.

Int Arch Otorhinolaryngol. 2014 Jul;18(3):294-302. doi: 10.1055/s-0034-1372512. Epub 2014 Apr 2. Review.

5.

A case of large cell neuroendocrine carcinoma of the rectum.

Muto M, Ichiki K, Muto M, Ishikawa C, Inoue M, Aoki T, Hashimoto M, Inaba S, Yamamoto M.

Nihon Shokakibyo Gakkai Zasshi. 2015;112(4):683-9. doi: 10.11405/nisshoshi.112.683.

PMID:
25843456
6.

DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity.

Kato T, Takata M, Kitaichi M, Kassai M, Inoue M, Ishikawa C, Hirose W, Yoshida K, Shimizu I.

Eur J Pharmacol. 2015 Jun 15;757:11-20. doi: 10.1016/j.ejphar.2015.03.024. Epub 2015 Mar 28.

PMID:
25823809
7.

Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.

Takai K, Chiyo N, Nakajima T, Nariai T, Ishikawa C, Nakatani S, Ikeno A, Yamamoto S, Sone T.

Bioorg Med Chem Lett. 2015 Apr 15;25(8):1705-8. doi: 10.1016/j.bmcl.2015.02.076. Epub 2015 Mar 7.

PMID:
25800114
8.

Activation of PKC-δ in HTLV-1-infected T cells.

Mori N, Ishikawa C, Senba M.

Int J Oncol. 2015 Apr;46(4):1609-18. doi: 10.3892/ijo.2015.2848. Epub 2015 Jan 26.

PMID:
25625567
9.

Inhibitory activities of selected Kampo formulations on human aldose reductase.

Onoda T, Ishikawa C, Fukazawa T, Li W, Obayashi M, Koike K.

BMC Complement Altern Med. 2014 Nov 6;14:435. doi: 10.1186/1472-6882-14-435.

10.

Production of a pharmaceutical intermediate via biohydroxylation using whole cells of Rhodococcus rubropertinctus N82.

Kimura T, Ishikawa C, Osorio-Lozada A, Robins KT, Hibi M, Ogawa J.

Biosci Biotechnol Biochem. 2014;78(10):1772-6. doi: 10.1080/09168451.2014.925781. Epub 2014 Jun 26.

PMID:
25273144
11.

Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression.

Koga S, Kojima A, Ishikawa C, Kuwabara S, Arai K, Yoshiyama Y.

Neurobiol Dis. 2014 Nov;71:180-92. doi: 10.1016/j.nbd.2014.08.015. Epub 2014 Aug 15.

12.

Dietary administration of Bacillus subtilis on hematology and non-specific immunity of Nile tilapia Oreochromis niloticus raised at different stocking densities.

Telli GS, Ranzani-Paiva MJ, Dias Dde C, Sussel FR, Ishikawa CM, Tachibana L.

Fish Shellfish Immunol. 2014 Aug;39(2):305-11. doi: 10.1016/j.fsi.2014.05.025. Epub 2014 May 28.

PMID:
24878743
13.

N-(18-hydroxylinolenoyl)-L-glutamine: a newly discovered analog of volicitin in Manduca sexta and its elicitor activity in plants.

Yoshinaga N, Ishikawa C, Seidl-Adams I, Bosak E, Aboshi T, Tumlinson JH, Mori N.

J Chem Ecol. 2014 May;40(5):484-90. doi: 10.1007/s10886-014-0436-y. Epub 2014 May 11.

PMID:
24817386
14.

Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.

Takai K, Nakajima T, Takanashi Y, Sone T, Nariai T, Chiyo N, Nakatani S, Ishikawa C, Yamaguchi N, Fujita K, Yamada K.

Bioorg Med Chem. 2014 Mar 1;22(5):1548-57. doi: 10.1016/j.bmc.2014.01.040. Epub 2014 Jan 31.

PMID:
24530032
15.

Triple-phase helical computed tomography in dogs with hepatic masses.

Kutara K, Seki M, Ishikawa C, Sakai M, Kagawa Y, Iida G, Ishigaki K, Teshima K, Edamura K, Nakayama T, Asano K.

Vet Radiol Ultrasound. 2014 Jan-Feb;55(1):7-15. doi: 10.1111/vru.12099. Epub 2013 Sep 18.

PMID:
24102918
16.

Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo.

Ishikawa C, Tanaka J, Katano H, Senba M, Mori N.

Mar Drugs. 2013 Sep 6;11(9):3410-24. doi: 10.3390/md11093410.

17.

Protein phosphatase 2A as a potential target for treatment of adult T cell leukemia.

Mori N, Ishikawa C, Uchihara JN, Yasumoto T.

Curr Cancer Drug Targets. 2013 Oct;13(8):829-42.

PMID:
24015987
18.

Anticancer effects of marine carotenoids, fucoxanthin and its deacetylated product, fucoxanthinol, on osteosarcoma.

Rokkaku T, Kimura R, Ishikawa C, Yasumoto T, Senba M, Kanaya F, Mori N.

Int J Oncol. 2013 Oct;43(4):1176-86. doi: 10.3892/ijo.2013.2019. Epub 2013 Jul 15.

PMID:
23857515
19.

Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB.

Ishikawa C, Mori N.

Int J Oncol. 2013 May;42(5):1786-92. doi: 10.3892/ijo.2013.1871. Epub 2013 Mar 28.

PMID:
23546309
20.

CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.

Ishikawa C, Kawakami H, Uchihara JN, Senba M, Mori N.

Biochim Biophys Acta. 2013 Jun;1833(6):1542-52. doi: 10.1016/j.bbamcr.2013.03.006. Epub 2013 Mar 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk